Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact,...
Keep Reading →
December 21 - Hedge Funds, News - Comments
Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return...
Keep Reading →
November 2 - Hedge Fund Investor Letters, News - Comments
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Keep Reading →
September 15 - Hedge Funds, News - Comments
If you are looking for the best ideas for your portfolio you may want to consider some of Miller Value Partners top stock picks. Miller Value Partners...
Keep Reading →
September 8 - Hedge Fund Investor Letters, News - Comments
Bain Capital’s New Fund Terms Pass Muster in New Mexico (The Wall Street Journal) Bain Capital’s latest flagship fund provides some fee flexibility...
Keep Reading →
August 26 - Hedge Funds, Insider Trading - Comments
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Keep Reading →
July 12 - Hedge Funds, News - Comments
In this article we will take a look at whether hedge funds think Teva Pharmaceutical Industries Limited (NYSE:TEVA) is a good investment right now. We...
Keep Reading →
June 8 - Hedge Funds, News - Comments
Operation Warp Speed: The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates...
Keep Reading →
May 31 - Stock Analysis - Comments
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
Keep Reading →
March 17 - Hedge Funds, News - Comments
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook...
Keep Reading →
December 7 - Hedge Funds, News - Comments
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due...
Keep Reading →
October 22 - Hedge Funds, News - Comments
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred...
Keep Reading →
June 10 - Hedge Funds, News - Comments
“October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers...
Keep Reading →
March 30 - Hedge Funds, News - Comments
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on...
Keep Reading →
December 9 - Hedge Funds, News - Comments
Warren Buffett is arguably the greatest investor of all time. Over his career, Buffett’s investing prowess formed one of the greatest conglomerates...
Keep Reading →
November 12 - News - Comments
SunPower Corporation (NASDAQ:SPWR) (The Motley Fool) What happened: Shares of solar manufacturer SunPower Corp. (NASDAQ:SPWR) fell as much as 12.4% in...
Keep Reading →
February 15 - Market Movers, News - Comments
Twitter Inc (NYSE:TWTR) (MarketWatch) Twitter Inc. TWTR, +15.64% shares soared 12.6% in premarket trading after the company delivered better-than-expected...
Keep Reading →
February 8 - Market Movers, News - Comments
In this article we are going to share highlights from Jana Partners’ 2017 Q4 investor letter. JANA Master Fund returned 5.6% net of fees and expenses...
Keep Reading →
January 25 - Hedge Fund Investor Letters, Hedge Funds, News - Comments
The top 10 generic pharmaceutical companies in 2017 operate in the relatively recession-proof pharmaceuticals industry which is immune from the vagaries...
Keep Reading →
December 13 - Lists, News - Comments
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in. These...
Keep Reading →
July 17 - Dividend Stocks, News - Comments
1. U.S. Stock Market: “U.S. equities traded higher on Wednesday as investors cheered the Federal Reserve’s plan for scaling back its massive...
Keep Reading →
May 24 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is combined...
Keep Reading →
March 20 - News, Stock Analysis - Comments
David Tepper of Appaloosa Management is one of the most closely followed hedge fund managers in the world. The outspoken billionaire investor is candid...
Keep Reading →
March 13 - Hedge Fund Analysis, Hedge Funds, News - Comments
The number of states accusing Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan N.V. (NASDAQ:MYL) for price collusion have risen as the list...
Keep Reading →
March 2 - News, Stock Analysis - Comments
An application for a new drug by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been accepted by the Food and Drug Administration. Teva’s...
Keep Reading →
March 1 - News, Stock Analysis - Comments
What are the 10 states with the highest opioid abuse rates? Opioid pain killers are generally a good thing. Without them, many patients would suffer substantially...
Keep Reading →
February 26 - Lists, News - Comments
Back in 2008, billionaire Warren Buffett made a bet that hedge funds will underperform index funds over the following decade. While the bet still has...
Keep Reading →
February 23 - Activism, Hedge Funds, News - Comments
Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories. This...
Keep Reading →
February 22 - News, Stock Analysis - Comments
Notable value investor and billionaire Michael Price recently has revealed his equity portfolio as of the end of 2016 via a 13F filing submitted with...
Keep Reading →
February 20 - Hedge Funds, News - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has announced the approval of AirDuo RespiClick and ArmonAir RespiClick by the U.S. Food and Drug...
Keep Reading →
February 2 - News, Stock Analysis - Comments
A U.S. court has rejected four claims of patent infringement from Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA). The asserted claims involved the...
Keep Reading →
January 31 - News, Stock Analysis - Comments
Patients with severe pain that demands long-term, around-the-clock treatment now have a new medication to try. They will now be able to use Vantreal ER...
Keep Reading →
January 19 - News, Stock Analysis - Comments
Brower Piven, a law firm specializing in securities litigation, is sending out an appeal reminding investors of Teva Pharmaceutical Industries Ltd (ADR...
Keep Reading →
December 30 - News, Stock Analysis - Comments
The Securities and Exchange Commission has revealed that Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) will have to pay more than $500 million...
Keep Reading →
December 28 - News, Stock Analysis - Comments
Billionaire Michael Price is an American value investor and hedge fund manager who founded MFP Investors, a New York-based investment fund, in 1988. Mr...
Keep Reading →
December 22 - Hedge Funds, News - Comments
John Paulson founded New York-based investment management firm Paulson & Company in 1994. He shot into prominence when he earned almost $4 billion...
Keep Reading →
December 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shareholders were treated to an unpleasant surprise by generics CEO Siggi Olafsson, who is said to...
Keep Reading →
December 7 - News, Stock Analysis - Comments
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down...
Keep Reading →
November 25 - Hedge Funds, News - Comments
The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY...
Keep Reading →
November 23 - News, Stock Analysis - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is alleged to have bought its way into boosting its sales in foreign countries including Russia,...
Keep Reading →
November 16 - News, Stock Analysis - Comments
It seems like Deja Vu all over again as pollsters and conventional wisdom were again proven wrong. Less than five months after the pro-Brexit side shocked...
Keep Reading →
November 9 - Market Movers, News - Comments
Although the non-farm payrolls for October came in worse than expected, at 161,000 versus the expected 175,000, volatility remains low on the Street as...
Keep Reading →
November 4 - Market Movers, News - Comments
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) will have to wait for a court ruling over its IP protection for its lifelong multiple sclerosis therapy...
Keep Reading →
November 1 - News - Comments
All three major indexes are in the red today, as the earnings results of several major companies including Apple Inc. (NASDAQ:AAPL) failed to meet expectations...
Keep Reading →
October 26 - Market Movers, News - Comments
Reports in the pharmaceutical space indicate that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) might be planning to acquire South Korea biosimilar giant...
Keep Reading →
October 19 - News, Stock Analysis - Comments
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) recently entered into an exclusive agreement with Celltrion, Inc. to commercialize P10 and CT-P6, the...
Keep Reading →
October 7 - News, Stock Analysis - Comments
All three indexes have opened relatively flat this morning as traders brace for the major events this month, the FOMC meeting and the informal Russia/...
Keep Reading →
September 15 - Commodities, Market Movers, News - Comments
After Friday’s sharp drop in equity prices, more investors are keeping tabs on the market to see whether the recent interest rate fears will cause...
Keep Reading →
September 12 - Market Movers, News - Comments
Interest rate-sensitive financial stocks are in the spotlight today after previously-dovish Boston Federal Reserve President Eric Rosengren said that...
Keep Reading →
September 9 - Market Movers, News - Comments
Billionaire Larry Robbins‘ famed hedge fund Glenview Capital recently has submitted its 13F filing with SEC for the reporting period ended June...
Keep Reading →
September 3 - Hedge Funds, News - Comments